Add a bookmark to get started

Lisa Haile

Lisa A. Haile

She has an in-depth understanding of the technology, the competition and claim construction, and is appreciated by clients for her ability to grasp novel areas of science extremely quickly.
Chambers USA

Dr. Lisa Haile concentrates on patent protection and IP transactional matters.

Dr. Haile has special technical experience in molecular biology, immunology, cell biology, regenerative medicine including ESCs, iPSCs, pSCs, gene editing, immuno-oncology, diagnostics, therapeutics, theranostics, drug delivery systems, host-vector systems, high throughput screening, and bioinformatics. She has particular experience with patentability, non-infringement and validity opinions; licensing strategies; FDA counseling; due diligence work in connection with venture capital, private and public financing; mergers and acquisitions in the life sciences industry; and strategic counseling for comprehensive life sciences patent portfolio management.

Bar admissionsCaliforniaDistrict of ColumbiaNew YorkUnited States Patent and Trademark Office

Recent Matters

Patentability, infringement and validity determinations, IP due diligence, licensing, development of IP policies and strategic counseling in the following areas: plants, antisense molecules, peptides, proteins, DNA, antibodies, vaccines, small molecules, diagnostics, therapeutics, theranostics, RNAi, gene editing, immuno-oncology, and bioinformatics.


US and International patent preparation and prosecution as well as patentability, infringement and validity determinations, inter partes review (IPR) petitions, licensing, and strategic counseling including patent term extensions through regulatory agencies.

  • J.D., California Western School of Law 1991
  • Ph.D., Microbiology and Immunology, Georgetown University School of Medicine 1987
  • B.A., Biology, Rollins College 1982


Chambers Global

  • Band 2, USA Life Sciences: IP/Patent Litigation (2021 - 2024)
  • Band 3, USA Life Sciences: IP/Patent Litigation (2020)

Chambers USA

  • Band 2, California Life Sciences: IP/Patent Litigation (2011, 2013 - 2015, 2019 - 2023)
  • Band 2, Nationwide Life Sciences: IP/Patent Litigation (2023)
  • Chambers USA notes, "Lisa Haile is able to draw on extensive technical expertise in areas such as cell and molecular biology, regenerative medicine and immunology, to advise on matters ranging from venture capital due diligence to patentability and licensing. She is particularly skilled in patent prosecution and portfolio management." Clients praise Lisa as "just incredible," and "one of the best IP lawyers in the country."
  • Band 1, California Intellectual Property: Patent Prosecution (2015 - 2023)
  • Chambers USA comments, "Lisa Haile is well versed in patent prosecution concerns arising in the life sciences sector, and frequently advises industry clients on matters ranging from patentability and portfolio management to FDA regulations and due diligence." Clients describe her as "highly knowledgeable," and "a fierce advocate," who "provides practical legal advice."
  • Band 3, Life Sciences: IP/Patent Litigation (2019) 
  • Band 4, California Intellectual Property: Patent (2012 - 2014) 

The Legal 500 United States

  • Leading Lawyer, Patents: Licensing (2022 - 2023)
  • The Legal 500 comments, "The San Diego-based Lisa Haile, who is skilled at handling mergers and acquisitions in the life sciences space as well as in the strategic counseling for comprehensive life sciences patent portfolio management, is another key name."
  • Recommended, Patents: Prosecution (including re-examination and post-grant proceedings) (2022 - 2023)
  • Clients say, "Lisa Haile is very, very good and producing very high-quality work. She is a very good strategist and is incredibly responsive." "Lisa Haile is extremely easy to work with and seems to be always available for any issue that comes up." "Lisa Haile is always on top of making sure the filings are strong and timely."
  • Recommended, Healthcare: Life Sciences  (2015 - 2021) 
  • Recommended, Cannabis (2021) 
  • Recommended, Intellectual Property Patents: Licensing (2018, 2021) 
  • Recommended, Intellectual Property Patents: Portfolio Management and Licensing (2016 - 2017) 
Other recognitions
  • Named to IAM Patent 1000: The World's Leading Patent Professionals (2019)
  • Recognized by LMG Life Sciences Awards as Patent Strategy & Management Attorney of the Year – California (2019) 
  • Named to Managing Intellectual Property's list of Top 250 Women in IP (2019)
  • Named to The Daily Transcript’s list of Top 100 Influential Leaders in San Diego (2016)
  • Named to The National Law Journal’s list of 75 Outstanding Women Lawyers (2015)
  • Named to The California Daily Journal's list of Top 25 IP Portfolio Managers (2009 - 2015)
  • Featured among the "Lawdragon 500" by Lawdragon Magazine in its annual list of "the nation's leading lawyers." The publication reported that "Haile's Ph.D. in microbiology and immunology played a big role in her emergence as one of the top patent lawyers in the world." (2014)
  • Named to Managing Intellectual Property’s list of "Top 250 Women in IP," which recognizes the top female intellectual property lawyers in the United States (2013 - 2014)
  • Named among IAM Patent 1000's list of The World's Leading Patent Practitioners. IAM interviewed lawyers and clients around the world to determine who companies turn to "when only the best patent work will do." (2014)
  • Recognized by Law360 as a female powerbroker and featured in a profile discussing breaking into an "old boys network" and offering advice to women lawyers (2013)
  • Named among Southern California's Top Rated Lawyers by the American Lawyer Media and Martindale-Hubbell, featured in the Los Angeles Times (2013)
  • Named among LMG Life Sciences' Life Sciences Stars for intellectual property (2013)
  • Named by the Daily Journal as one of the top 25 biotech lawyers in California. This is the first year that the Daily Journal recognized lawyers in this category as providing overall counsel to companies in the biotechnology space. (2011)
  • Named Best Lawyers® in San Diego and listed in San Diego Magazine (2012) 
  • Named among the San Diego Daily Transcript list of San Diego County's Top Attorneys (2008 - 2010)
  • Listed in the International Who's Who of Life Sciences Lawyers (2008)
  • Selected to the San Diego Super Lawyers list (2008)
  • Named as one of the Top 45 Lawyers under 45 by The American Lawyer (January 2003)
  • Named to The Best Lawyers in America®


  • Life Sciences Spotlight Asia Pacific, 6 May 2015
  • European Court of Justice: landmark decision on patentability of stem cells, 19 Dec 2014
  • Patentability of isolated nucleic acid: US vs. Australia, 18 Dec 2014
  • DLA Piper's Global Life Sciences Sector, 6 Nov 2013
  • "FDA Catches Up with Health IT Revolution: Convergence of Healthcare and IT Has FDA Scrambling to Update Policies," Genetic Engineering & Biotechnology News, February 1, 2012 (co-author)


  • The Pulse Webinar: Patent law in the life sciences sector - US and Australian perspectives, Webinar, 28 October 2015

Media Mentions

Civic and Charitable

  • Scientific Advisory Board, GT Biopharma (2015 – present)
  • Advisory Council, California State University San Marcos, College of Arts and Sciences (2009)
  • BIOCOM Science and Technology Committee, Capital Markets Committee, IP Committee
  • BIOCOM, AWIS, Licensing Executives Society (LES), UCSD Connect, Athena and American Liver Foundation
  • Board Member, Athena, Vice President (2005 – 2006), President (2006 – 2007)
  • Board Member, American Liver Foundation, Vice President (2005 – 2006), President (2006 – 2008)
  • Board Member and General Counsel, BIOCOM (2005 – present)

Teaching Experience

  • Adjunct Professor, Patent Law, California Western School of Law

Memberships And Affiliations

  • San Diego Intellectual Property Law Association, President (1997 – 1999)
  • San Diego, California and American Bar Associations
  • American Intellectual Property Law Association
  • Intellectual Property Owners Association